Insider Selling: GenMark Diagnostics, Inc (GNMK) CFO Sells $17,029.24 in Stock

Insider Selling: GenMark Diagnostics, Inc (GNMK) CFO Sells $17,029.24 in Stock

Scott Mendel also recently made the following trade(s):

GenMark Diagnostics, Inc (NASDAQ:GNMK) CFO Scott Mendel sold 1,268 shares of the business’s stock in a transaction that occurred on Tuesday, May 16th. The stock was sold at an average price of $13.43, for a total value of $17,029.24. The sale was disclosed in a filing with the SEC, which is available through the SEC website.

Shares of GenMark Diagnostics, Inc (NASDAQ:GNMK) traded up 0.15% during midday trading on Wednesday, reaching $12.94. The company had a trading volume of 208,870 shares. The company’s market capitalization is $609.31 million. GenMark Diagnostics, Inc has a 12 month low of $7.82 and a 12 month high of $13.67. The firm’s 50 day moving average price is $12.97 and its 200-day moving average price is $12.28.

GenMark Diagnostics (NASDAQ:GNMK) last released its quarterly earnings results on Tuesday, May 2nd. The medical equipment provider reported ($0.30) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.28) by $0.02. GenMark Diagnostics had a negative net margin of 98.17% and a negative return on equity of 114.35%. The company had revenue of $12.54 million for the quarter, compared to the consensus estimate of $12.55 million. Analysts anticipate that GenMark Diagnostics, Inc will post ($0.96) earnings per share for the current fiscal year.

Several hedge funds have recently added to or reduced their stakes in GNMK. HighTower Advisors LLC boosted its stake in GenMark Diagnostics by 4,380.1% in the third quarter. HighTower Advisors LLC now owns 2,074,347 shares of the medical equipment provider’s stock valued at $24,477,000 after buying an additional 2,028,046 shares during the period. Thrivent Financial for Lutherans bought a new stake in GenMark Diagnostics during the fourth quarter valued at approximately $3,644,000. Metropolitan Life Insurance Co. NY boosted its stake in GenMark Diagnostics by 10.2% in the fourth quarter. Metropolitan Life Insurance Co. NY now owns 29,013 shares of the medical equipment provider’s stock valued at $355,000 after buying an additional 2,689 shares during the period. FMR LLC boosted its stake in GenMark Diagnostics by 7.9% in the fourth quarter. FMR LLC now owns 6,960,646 shares of the medical equipment provider’s stock valued at $85,198,000 after buying an additional 511,563 shares during the period. Finally, Morgan Stanley boosted its stake in GenMark Diagnostics by 45.5% in the third quarter. Morgan Stanley now owns 2,829,658 shares of the medical equipment provider’s stock valued at $33,390,000 after buying an additional 884,575 shares during the period.

Several brokerages recently commented on GNMK. BTIG Research reissued a “buy” rating and set a $17.00 target price on shares of GenMark Diagnostics in a report on Wednesday, May 17th. Needham & Company LLC reissued a “buy” rating and set a $16.00 target price (up previously from $15.00) on shares of GenMark Diagnostics in a report on Wednesday, May 3rd. Zacks Investment Research cut GenMark Diagnostics from a “buy” rating to a “hold” rating in a report on Wednesday, May 3rd. Finally, Canaccord Genuity reissued a “buy” rating and set a $14.00 target price on shares of GenMark Diagnostics in a report on Tuesday, February 28th. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the company’s stock. GenMark Diagnostics has a consensus rating of “Buy” and a consensus target price of $15.17.

About GenMark Diagnostics

GenMark Diagnostics, Inc is a molecular diagnostics company. The Company is focused on developing and commercializing multiplex molecular tests that aid in the diagnosis of complex medical conditions. It develops and commercializes multiplex molecular tests based on its eSensor electrochemical detection technology.new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “NASDAQ:GNMK”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Related posts

Leave a Comment